That's what makes the market. If it was all buyers there would be no sellers. Where there is a long there is a short. It's diverse and opinionated and everyone wants the biggest piece of the pie they can get. Nothing we can do but do our best due diligence and make our own decisions. Most of us are wrong a lot of the time, but then again so is Cramer.
Sentiment: Strong Buy
This is just a fancy way of saying that stocks bounce around a lot, and usually trade in the same range, until they make a move in one direction or another, based on a catalyst or major development.
The Financial Adviser is IN. 5 cents please.
A gap is an area on a chart where no buying and selling took place . So if stock A closes at a 52 week high of 10.00 and opens the next day at 11.00 you have a 1.00 gap. I did a study on gaps several years ago using TNA and if I remember right about 80% were filled within a few days.--Point is if a stock goes from 10 to 11 for no real good reason the gap will be filled nearly 100% of the time.
also the full candle must close the gap to be a true gap fill not simply the wick (top or bottom) of the candle. so, as much as i love a stock shooting up just like the next guy or gal, i temper my joy when i see the gap because it will almost always be filled before the upward movement is be sensibly resumed. we will have our very own science experiment with the kerx gap at 13.64. note the wicks have met at oh, say 13.71 so possibly a full bar to follow. and no, that isnt meant to sound perverted, meeting wicks and all....
How bout people just buy the stock....... Does Kerx have any real competition, don't we already have a drug that is being sold, script growth is excellent...... How about people just buy the stock and stop with the swing trading, day trading, momentum trading etc....... Just buy the stock and relax.
not a myth imo. if a fundametal changes forever, a breakaway gap may never be filled for the rest of the life of the stock...however, gaps of exuberant emotional buying are normally filled sooner or later. it is also a sort of reference point for the stock operator imo. looking at charts in candle stick form is best for gap hunting and if you look at enough you may notice a pattern. the strongest charts tend to have solid candles with no spaces in between and reflects rational coherent share buying. when you get those surprise/emotional breakaways, no matter the size, you have more spontaneous impulse buys that are alos far quicker to sell their short term gains. needless to say i dont buy shortly after a gap up...
It's a myth. Stocks fill gaps. Except when they don't....
But the myth was useful for the shorts yesterday. It gave them a target, which they almost made.
They might try again today. But for this week, they're about to run out of time.
A press release on these abstracts would be an excellent riposte to the SA piece. In 2013 and 2014, however, the company does not seem to have done press conferences around the NKF Spring Clinical Meetings. Keryx is now a commercial company; perhaps they will just let Friday's script numbers speak for themselves.
Timing of that is perfect!
Some other good abstracts there too. Drs. Lewis, Fishbane, Black, Sika, etc., strike again.
Focus on Diabetic Kidney Care at NKF
—Experts parse new joint guidance from top diabetes and nephrology organizations.
by Kristina Fiore
Staff Writer, MedPage Today
DALLAS -- New guidance for diabetic kidney disease will be a central part of the discussion at this year's National Kidney Foundation meeting.
Last October, four major diabetes and kidney organizations -- the National Institute of Diabetes and Digestive and Kidney Diseases, the American Diabetes Association, the NKF, and the American Society of Nephrology -- published a joint statement on advances in diabetic kidney disease in the journal Diabetes Care, which was the result of an earlier consensus conference.
Adam Whaley-Connell, DO, of the University of Missouri, a co-author of the statement and chair of the scientific program committee for this year's meeting, will discuss the paper, along with other colleagues, at a session on Friday.
Other Hallway Discussions
Whaley-Connell said this year's meeting is taking a look into an issue relevant to its host state: disparities in kidney care. Texas' status as a border state raises questions about whether patients have access to care, Whaley-Connell said, adding that there are several other socio-economic and ethnic concerns that local nephrologists must tackle in practice.
Nephrologists will also be asking questions about hyperkalemia treatment, which has become a hot area for drug development. Currently, only sodium polystyrene sulfonate (Kayexalate) is available to treat high potassium levels, but two new drugs have reported data from late-stage trials -- ZS-9 and patiromer -- and may soon be clinically available.
High phosphorus levels have also been thrown into the spotlight with the approval last September of ferric citrate (Auryxia), which is looking to take over some market share from the old staple sevelamer.
Sentiment: Strong Buy
SA keeps erasing my comments. seems like only the author is permitted to be an arrogant condescending twhat. did you click on the link to that website of his? LOL what a farce. those are the kind of filthy sites that make you want to throw your computer out the window.
clown writes an ''article'' and 0 people come to his defense...the comments are great.. I helped!
Sentiment: Strong Buy
Lots of people spinning negativity, crying about all kinds of irrelevant things..... there is no negativity------- our script numbers are going to improve every week over every month for years. Our company and personal profits are going to increase every week over every month for years as well.
You would be surprised how many folks from hedgies to private capital give these boards a read, as there is no flow of info, any other way other than an 8k, but here we bring raw data, where it doesn't come from anywhere else. Funkmeisters also get to foment distractions and dispersions to suit the swing trade, or the short trade so unless the status quo works for this board, maybe we owners try a new direction.
LOL..there's no way the 12 or so people here can influence a stock in any direction. If someone makes you mad, ignore them.
Sentiment: Strong Buy
Only american has diarrhea issue with ferric citrate but japaness pt can tolerate it and keep taking it. American are #$%$!